申请人:Global Blood Therapeutics, Inc.
公开号:EP3919056A1
公开(公告)日:2021-12-08
Provide herein are compounds containing an aldehyde group and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.
本文提供了含有醛基的化合物和适合作为血红蛋白调节剂的药物组合物、制备它们的方法和中间体,以及将它们用于治疗由血红蛋白介导的疾病和将从组织和/或细胞氧合中获益的疾病的方法。